COMPANY
Alloplex Biotherapeutics
Alloplex Biotherapeutics is a privately-owned company a new era in cellular immunotherapy for the treatment of cancer and autoimmunity. From company website Source · Oct 12, 2026
Timeline
- Trial start Phase 1: Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies source ↗
Clinical trials (lead sponsor) 1
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT05237206 | Study of SUPLEXA in Patients With Metastatic Solid Tumours and Haematologic Malignancies | Phase 1 | Completed | Apr 28, 2022 | Jul 23, 2024 (actual) |